当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析

前沿生物-U

(688221)

  

流通市值:73.53亿  总市值:73.53亿
流通股本:3.75亿   总股本:3.75亿

前沿生物-U(688221)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.27亿元,每股收益0.61元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益110827.79万元,未分配利润-199714.12万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产185045.09万元,负债74217.31万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入297,131,734.61123,386,656.86103,373,939.2258,639,825.88
营业总成本74,623,130.61378,879,481.97262,354,974.69159,170,063.11
其他经营收益
营业利润227,645,045.69-267,720,614.09-159,475,988.33-97,148,403.94
利润总额227,393,754.18-268,053,032.03-159,808,526.07-97,352,610.68
净利润227,393,754.18-268,053,032.03-159,808,526.07-97,352,610.68
每股收益
其他综合收益40,776.315,381.2717,530.7616,756.4
综合收益总额227,434,530.48-268,037,650.76-159,790,995.31-97,335,854.28
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,287,817,815.851,004,818,169.91,055,901,026.231,076,719,889.03
非流动资产:
非流动资产合计562,633,115.57573,492,344.21581,489,363.29586,508,009.37
资产总计1,850,450,931.421,578,310,514.111,637,390,389.521,663,227,898.4
流动负债:
流动负债合计363,781,884.82410,339,338.82390,421,353.95373,554,542.67
非流动负债:
非流动负债合计378,391,172.08291,102,383.29265,448,633.98245,697,813.11
负债合计742,173,056.9701,441,722.11655,869,987.93619,252,355.78
所有者权益(或股东权益):
归属于母公司股东权益合计1,108,277,874.52876,868,792981,520,401.591,043,975,542.62
股东权益合计1,108,277,874.52876,868,792981,520,401.591,043,975,542.62
负债和股东权益合计1,850,450,931.421,578,310,514.111,637,390,389.521,663,227,898.4
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计328,879,067.99119,691,620.1588,991,128.8356,576,387.96
经营活动现金流出小计110,999,278.73346,279,922.92240,780,717.43154,804,229.65
经营活动产生的现金流量净额217,879,789.26-226,588,302.77-151,789,588.6-98,227,841.69
投资活动产生的现金流量:
投资活动现金流入小计651,741,137.273,013,117,222.182,479,193,958.121,556,639,373.5
投资活动现金流出小计912,280,941.052,840,434,170.782,423,745,665.311,466,219,991.96
投资活动产生的现金流量净额-260,539,803.78172,683,051.455,448,292.8190,419,381.54
筹资活动产生的现金流量:
筹资活动现金流入小计142,258,756.4361,850,023.44289,559,879.25216,774,000
筹资活动现金流出小计82,281,460.41386,272,934.27344,776,026.5293,954,198.38
筹资活动产生的现金流量净额59,977,295.99-24,422,910.83-55,216,147.25-77,180,198.38
汇率变动对现金及现金等价物的影响-60,241.86-47,436.25-26,046.19-15,167.51
现金及现金等价物净增加额17,257,039.61-78,375,598.45-151,583,489.23-85,003,826.04
期末现金及现金等价物余额187,601,398.98170,344,359.3797,136,468.59163,716,131.78
补充资料:
现金及现金等价物的净增加额--78,375,598.45--85,003,826.04
最新报告期:2026-05-19
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长江证券刘长洪,彭英骐-0.49-0.45-0.442026-05-19
国联民生张金洋,胡偌碧,郭广洋0.07-0.26-0.242026-04-30
开源证券余汝意,巢舒然-0.07-0.51-0.572026-04-28
湘财证券蒋栋0.080.20--2026-03-28
TOP↑